- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Changing Outcomes for Pregnancy-Related Mortality for Vulnerable Women
Women in the United States suffer from maternal mortality rates not seen elsewhere in developed countries, and nowhere is that more true than among patients served by Medicaid. Although it is a national epidemic, inadequate maternal care disproportionately affects minority women and the 43% of US births financed by Medicaid. On this episode, we speak with an executive vice president of Avia Health Innovation, which is trying to address this issue in conjunction with 30 healthcare systems.
Women in the United States suffer from maternal mortality rates not seen elsewhere in developed countries, and nowhere is that more true than among patients served by Medicaid. Although it is a national epidemic, inadequate maternal care disproportionately affects minority women and the 43% of US births financed by Medicaid.
On this episode, we speak with Amy Dirks Stevens, executive vice president of Avia Health Innovation, which in 2018 launched the Medicaid Transformation Project, which aims to improve healthcare and related social needs, including behavioral health and mental health. In September, the organization began working with 30 health systems to try and change the course of outcomes for women and their infants.
Listen above or or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
